؊/؊ mice, deficient in CD21 and CD35 (complement receptors 2 and 1, respectively), were infected with Borrelia burgdorferi to assess the role of these receptors in a chronic bacterial infection. Although CD21/35 ؊/؊ mice on both C57BL/6 and BALB/c backgrounds produced less B. burgdorferi-specific antibodies than did wild-type mice, spirochete levels and arthritis severity were similar.
Complement plays an important part in the clearance of bacteria. The decoration of pathogen antigens with complement fragments provides signals important for the opsonization of bacteria and induction of inflammatory responses. In the mouse, CD21 and CD35 (complement receptors 2 and 1, respectively; CD21/35) are spliced products from the Cr2 gene and serve as receptors for complement breakdown products.
On B cells, CD21/35 functions as the B-cell coreceptor and augments B-cell signaling (5). Mice lacking CD21/35 (CD21/ 35
Ϫ/Ϫ ) mount decreased antibody responses to T-cell-dependent and T-cell-independent antigens, with an impairment in the immunoglobulin G3 (IgG3)-specific antibody response (5) . Consequently, CD21/35 Ϫ/Ϫ mice were more susceptible to lethal Streptococcus pneumoniae infection (6) . These studies reveal an important role for CD21/35 in protective antibody responses during acute bacterial infection; however, the role of these proteins during a chronic bacterial infection has not been addressed.
Infection of mice with the spirochete Borrelia burgdorferi provides an excellent model for understanding host-pathogen interactions involved in chronic infection. Arthritis caused by persistent infection of the spirochete within joint tissue appears to result from the sustained inflammatory challenges to the host from the bacterial components (18) . Bacterium-specific antibodies produced during infection are not causative of or protective against acute Lyme arthritis in mice; however, they are important for controlling spirochete growth and resolution of disease (2, 14) .
B. burgdorferi has evolved mechanisms to evade the host immune response, including resistance to host complement. B. burgdorferi is able to bind host complement regulatory proteins factor H and factor H-like 1, which permits the bacteria to evade complement-mediated killing (1, 4, 7-9, 13, 17) . Additionally, higher spirochete levels and generally higher histopathology scores are found in joint tissue of C3 Ϫ/Ϫ mice (10). In these mice, anti-B. burgdorferi IgG levels were reduced compared to those in the wild type. These data suggest a role for complement proteins and their receptors in the immune response against B. burgdorferi.
In this study, we used B. burgdorferi infection to assess the role of complement receptor proteins CD21 and CD35 in a chronic bacterial infection. CD21/35 Ϫ/Ϫ mice were generated as previously described (6) and used at the 10th generation backcross to both C57BL/6 and BALB/c mice.
To assess the role of complement receptor proteins CD21 and CD35 in B. burgdorferi-specific antibody production, wildtype and CD21/35 Ϫ/Ϫ animals on both the BALB/c and C57BL/6 backgrounds were infected intradermally with a cloned N40 isolate of B. burgdorferi that had been passaged three times (provided by S. Barthold, University of California, Davis). To achieve equivalent disease severity on both backgrounds, mice on the BALB/c background received 2 ϫ 10 4 bacteria, whereas C57BL/6 mice received 2 ϫ 10 3 bacteria (12). C3H mice were infected with 2 ϫ 10 3 bacteria as positive controls for infection. Bacterium-specific and total antibody titers were measured (12) at 2 and 4 weeks postinfection. B. burgdorferi-specific IgG3 antibodies were significantly decreased at 4 weeks postinfection in CD21/35 Ϫ/Ϫ animals on the C57BL/6 background, whereas a less drastic decrease was observed on the BALB/c background (Table 1) . CD21/35 Ϫ/Ϫ mice produced increased bacterium-specific IgM antibodies on the BALB/c background. Knockout (KO) animals on both strain backgrounds produced significantly less B. burgdorferispecific IgG2b (Table 1) . Collectively, CD21/35 Ϫ/Ϫ mice had varied abilities to produce bacterium-specific antibodies im- Ϫ/Ϫ mice, but they were lower than those in infected C57BL/6 or C3H animals. Ϫ/Ϫ and wild-type mice recognized similar proteins in B. burgdorferi lysates (Fig.  1) . Sera from infected CD21/35 Ϫ/Ϫ and wild-type mice were also analyzed for antibody against the C6 peptide of the VlsE variable lipoprotein of B. burgdorferi, which has been used diagnostically for Lyme borreliosis in humans (11) . There were no significant differences in anti-C6 peptide antibody levels between wild-type and CD21/35-deficient mice on both the C57BL/6 and BALB/c backgrounds (data not shown). In brief, CD21/35 Ϫ/Ϫ mice appear to recognize and mount antibody responses against a variety of B. burgdorferi antigens, including lipoproteins, albeit producing lower levels of B. burgdorferispecific antibodies.
Bacterium-specific antibodies produced during infection play a role in controlling bacterial numbers and resolution of disease (14) . To consider the effect of decreased B. burgdorferispecific antibody responses in the CD21/35 Ϫ/Ϫ mouse, spirochete numbers and arthritis severity of the rear ankle joints of infected animals were assessed by quantitative PCR as described in detail in references 15 and 19. Deficiency in CD21/35 did not have an effect on B. burgdorferi numbers in ankle tissue 4 weeks postinfection (Fig. 2) , indicating that the antibodies produced by a CD21/35 Ϫ/Ϫ animal are sufficient to control spirochete numbers. Spirochete numbers in the joint tissue of BALB/c mice correlates with arthritis severity (12) . Arthritis severity within the ankle joints of infected mice did not differ significantly between wild-type and CD21/35-deficient mice as seen by ankle swelling and histological analysis ( Table 2) .
Converse to the acute bacterial infection with S. pneumoniae, CD21/35 Ϫ/Ϫ mice demonstrated the ability to control B. burgdorferi infection to wild-type levels regardless of an altered repertoire of antibodies against the bacteria. This may be best explained by the role of antibodies in protecting the host against bacterial infections. IgG3 is the major mouse IgG isotype produced in response to T-cell-independent type 2 antigens like pneumococcal polysaccharides (16) . Conversely, the immune response against Borrelia antigens uses both innate antibodies, like IgG3 and IgM, and those isotypes which require T-cell help, like IgG2a/b (14) . Complement proteins may be more critical adjuvants for immune responses against S. pneumoniae polysaccharides than B. burgdorferi lipoproteins. The evasion of host complement activation by the more recently described B. burgdorferi CRASP proteins may be more critical for bacterial survival during the initial infection. Complement receptors CD21/35, on the other hand, would have a more significant role in complement-mediated immune responses to the bacteria within the splenic environment, like antibody production. The data presented here suggest that complement receptors CD21 and CD35 do not have a direct role in regulating spirochete numbers, and the ability of CD21/ 35 Ϫ/Ϫ mice to control B. burgdorferi infection suggests that B. burgdorferi does not have an advantage in a host lacking complement receptors 1 and 2. 
